Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Clinical Trial
. 2007 Apr 15;109(8):3279-83.
doi: 10.1182/blood-2006-08-040709. Epub 2006 Dec 7.

Vitamin K-containing Dietary Supplements: Comparison of Synthetic Vitamin K1 and Natto-Derived menaquinone-7

Affiliations
Clinical Trial

Vitamin K-containing Dietary Supplements: Comparison of Synthetic Vitamin K1 and Natto-Derived menaquinone-7

Leon J Schurgers et al. Blood. .

Abstract

Vitamin K is a cofactor in the production of blood coagulation factors (in the liver), osteocalcin (in bone), and matrix Gla protein (cartilage and vessel wall). Accumulating evidence suggests that for optimal bone and vascular health, relatively high intakes of vitamin K are required. The synthetic short-chain vitamin K(1) is commonly used in food supplements, but recently the natural long-chain menaquinone-7 (MK-7) has also become available as an over-the-counter (OTC) supplement. The purpose of this paper was to compare in healthy volunteers the absorption and efficacy of K(1) and MK-7. Serum vitamin K species were used as a marker for absorption and osteocalcin carboxylation as a marker for activity. Both K(1) and MK-7 were absorbed well, with peak serum concentrations at 4 hours after intake. A major difference between the 2 vitamin K species is the very long half-life time of MK-7, resulting in much more stable serum levels, and accumulation of MK-7 to higher levels (7- to 8-fold) during prolonged intake. MK-7 induced more complete carboxylation of osteocalcin, and hematologists should be aware that preparations supplying 50 mug/d or more of MK-7 may interfere with oral anticoagulant treatment in a clinically relevant way.

Similar articles

See all similar articles

Cited by 61 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback